Richard H. Porter

Functional characterization of agonists at recombinant human 5‐HT_2A, 5‐HT_2B and 5‐HT_2C receptors in CHO‐K1 cells

Richard H. Porter, Karen Benwell, Helen Lamb et al. · British Journal of Pharmacology · 1999 · 356 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity

Richard H. Porter, Georg Jaeschke, Will Spooren et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 314 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Anatomy and physiology of glutamate in the CNS.

J. Timothy Greenamyre, Richard H. Porter · PubMed · 1994 · 240 citations

Life Sciences, Neuroscience, Pharmacology +17

Competitive antagonism at metabotropic glutamate receptors by (S) -4-carboxyphenylglycine and (RS) -α-methyl-4-carboxyphenylglycine

Sean A. Eaton, David E. Jane, Philip L. Jones et al. · European Journal of Pharmacology Molecular Pharmacology · 1993 · 219 citations

Life Sciences, Neuroscience, Pharmacology +14

Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat Striatum

James G. Greene, Richard H. Porter, Robert V. Eller · Journal of Neurochemistry · 1993 · 205 citations

Life Sciences, Neuroscience, Pharmacology +15